Skip to content

Brought to you by

Dentons logo in black and white

Dentons Canada Regulatory Review

The latest information and developments on regulatory law across Canada.

open menu close menu

Dentons Canada Regulatory Review

  • Home
  • About Us
  • Dentons COVID-19 hub

#Eatclean #HeartHealth #Getyourstepsin! Will your health and fitness app be regulated as a medical device in Canada?

By Monica Song and Yulia Konarski
September 23, 2022
  • Health
  • Regulatory
Share on Facebook Share on Twitter Share via email Share on LinkedIn

More and more consumers are using devices as an integral part of their personal health and fitness regimes. In response, businesses are developing and marketing an array of innovative software applications represented for a variety of health-related uses, from monitoring heart rate and tracking step count to calorie counters, nutrition advice and online fitness classes.

As the range of service offerings is continually expanding to address management and prevention of prevalent conditions, including obesity, abnormal cardiac activity, gut health, etc., so is the risk that an application is considered a “medical device” within the meaning of the Medical Devices Regulations. 

It is critical that businesses ask the question “will my application, as proposed, be regulated as a medical device?” before marketing the app.

The definition of a “medical device” is quite broad and includes anything that is manufactured, sold or represented for use in “diagnosing, treating, mitigating or preventing a disease, disorder or abnormal physical state, or any of their symptoms in human beings,” and also in “restoring, modifying or correcting the body structure of human beings or the functioning of any part of the bodies of human beings.” Arguably, under a broad interpretation, a recommended daily step count / tracker may be considered as represented for use in preventing obesity and as such, may be considered a “medical device.”

In practice, Health Canada does not enforce the legislation (Food and Drugs Act) against certain products.  In particular, Health Canada has indicated that software applications that meet exclusion criteria detailed in Health Canada guidance on the topic are excluded from regulation as a medical device, notwithstanding that the software may be captured by the legal definition of a “medical device.” The policy rationale behind this administrative stance is based on the view that software apps intended to support or encourage a healthy lifestyle should not be regulated as medical devices.  Subject to a case-by-case assessment of the functions, features and claims associated with wellness apps, a case for their exclusion could be made. 

Excluding software applications that pose a low risk of potential harm to human health and safety from being regulated as medical devices would also align with Health Canada’s broader compliance and enforcement policy, which prioritizes strict compliance of health products, including medical devices, that pose a higher risk of potential harm to the health and safety of consumers. 

It remains critically important to undertake a case-by-case assessment under applicable laws and regulations before marketing new wellness app products or features. 

For questions regarding classification as a medical device or risk mitigation strategies in marketing and advertising of new health and fitness applications, please contact Monica Song (monica.song@dentons.com ) and Yulia Konarski (yulia.konarski@dentons.com).

Share on Facebook Share on Twitter Share via email Share on LinkedIn
Subscribe and stay updated
Receive our latest blog posts by email.
Stay in Touch
Monica Song

About Monica Song

Monica Song is the national co-leader of Dentons Canada’s Regulatory group. Monica is a senior administrative and public policy lawyer with a deep understanding of the Canadian legislative and public policy landscape who specializes in advising clients spearheading growth and innovation in the digital economy.

All posts Full bio

Yulia Konarski

About Yulia Konarski

Yulia Konarski is an associate in our Regulatory group with a practice that focuses on regulated products under the Food and Drugs Act, including food, drugs, natural health products, cosmetics and medical devices. Yulia regularly advises clients about their obligations in relation to importing and selling these products into Canada.

All posts Full bio

RELATED POSTS

  • Environmental
  • ESG
  • Regulatory
  • Securities

Consultation Period for CSA Regulation Respecting Disclosure of Climate-related Matters ending February 16, 2022

By Dina Awad and Jade Lemieux | February 9, 2022
  • Regulatory

Competition Act and Investment Canada Act thresholds for Canadian M&A transactions confirmed for 2020

By Adam S. Goodman, Sandy Walker, Barry Zalmanowitz, KC, and Simon Kupi | April 10, 2020
  • ESG
  • Modern Slavery
  • Regulatory

Canada’s modern slavery framework: New reporting obligations

By Paul Lalonde, Yasmin Shaker, Sean Stephenson, and Daniela Acevedo | November 16, 2022

About Dentons

Redefining possibilities. Together, everywhere. For more information visit dentons.com

Grow, Protect, Operate, Finance. Dentons, the law firm of the future is here. Copyright 2023 Dentons. Dentons is a global legal practice providing client services worldwide through its member firms and affiliates. Please see dentons.com for Legal notices.

Check out more at Dentons.com

Due diligence in Canadian defence and dual-use investment

This insight is a companion to Venture capital opportunities in Canada’s defence sector which addresses the market landscape, government investment vehicles and the strategic opportunity for venture capital in Canadian [...]

Global data privacy and AI case law review – June 2026

Global: Welcome to the June edition of Dentons' global data privacy and AI case law review. This update contains submissions from Dentons colleagues across the world, from the UK and [...]

Carbon market in Québec: New draft regulation proposes key changes to the cap-and-trade system

On May 20, 2026, Québec released a draft regulation amending its Regulation respecting a cap-and-trade system for greenhouse gas emission allowances. [...]

Categories

Dentons logo in black and white

© 2026 Dentons

  • Legal notices
  • Privacy policy
  • Terms of use
  • Cookies on this site